tirzepatide glp 1 agonist Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Understand GLP-1/GIP Dual Agonist Tirzepatide
Description
An analysis of the ELIXA trial data indicated that short-term GLP-1RAs may also have renal protective effects, analogous to long-acting GLP-1RAs [47]
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects
3.2 Clinical application of GLP-1RAs GLP-1RA has been widely acknowledged at home and abroad for its hypoglycemic effects, safe use and beneficial effect on human metabolism
References Australian Diabetes Society and Australian and New Zealand College of Anaesthetists
The half-life of liraglutide is 12.6 hours (19), and it is administered once daily at any time without regard to meals (14)
